🇺🇸 FDA

Intelligence · Patent portfolio

United Therapeutics Europe Patents

Full USPTO pharma patent portfolio for United Therapeutics Europe — grant dates, expiration, and drug cross-links.

Patents
3,720
Expiring ≤24m
234

Quick answer

United Therapeutics Europe has 3,720 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 234 expire within 24 months — use filters for patent-cliff planning.

Page 43 of 78

  1. US 8685396

    Monoclonal antibodies that neutralize anthrax protective antigen (PA) toxin

    Expires Mon Mar 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 8680046

    Inhibitors of viral integrase and methods of use

    Expires Mon Mar 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 8680056

    Antiproliferative factor and methods of use

    Expires Mon Mar 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 8680065

    Oligonucleotides of human endogenous retrovirus 9 (ERV-9) long terminal repeat (LTR) and methods of use

    Expires Mon Mar 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 8680066

    Methods for determining and inhibiting rheumatoid arthritis associated with the BRAF oncogene in a subject

    Expires Mon Mar 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 8673629

    Recombinant Rift Valley fever (RVF) viruses and methods of use

    Expires Mon Mar 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 8673888

    Depsipeptide for therapy of kidney cancer

    Expires Mon Mar 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 8673316

    Avirulent, immunogenic flavivirus chimeras

    Expires Mon Mar 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 8673292

    Pure populations of astrocyte restricted precursor cells and methods for isolation and use thereof

    Expires Mon Mar 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 8673333

    Cross-linked polymer matrices, and methods of making and using same

    Expires Mon Mar 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 8664183

    SPANX-B polypeptides and their use

    Expires Mon Feb 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 8663622

    Recombinant vaccine viruses expressing IL-15 and methods using the same

    Expires Mon Feb 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 8663968

    Simian T-cell lymphotropic virus

    Expires Mon Feb 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 8658694

    Buffer solutions having selective bactericidal activity against gram negative bacteria and methods of using same

    Expires Mon Feb 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 8653137

    Buffer solutions having selective bactericidal activity against gram negative bacteria and methods of using same

    Expires Mon Feb 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 8652458

    Tissue graft with non-aligned fiber matrix retains mesenchymal progenitor cells on the non-injury-facing side

    Expires Mon Feb 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 8652512

    Nebulized liposomes for the pulmonary application of drug compounds

    Expires Mon Feb 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 8652787

    Use of ERBB4 as a prognostic and therapeutic marker for melanoma

    Expires Mon Feb 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 8647633

    Recombinant F1-V plague vaccine

    Expires Mon Feb 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 8647818

    Molecular scaffolds for HIV-1 immunogens

    Expires Mon Feb 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 8642048

    Multiple antigenic peptides immunogenic against Streptococcus pneumonia

    Expires Mon Jan 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 8637050

    Peptide vaccines against group A streptococci

    Expires Mon Jan 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 8636978

    Cyclized NGR peptide compounds, compositions, and methods of their use

    Expires Mon Jan 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 8637036

    Neutralizing antibodies to HIV-1 and their use

    Expires Mon Jan 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 8637041

    Secreted Campylobacter flaggella coregulated proteins as immunogens

    Expires Mon Jan 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 8637049

    Attenuated live vaccines for aquatic animals

    Expires Mon Jan 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 8637310

    Use of a rock inhibitor to sustain primary human keratinocytes in a proliferative state

    Expires Mon Jan 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 8637560

    Imidazolidinone compounds, methods to inhibit deubiquitination and methods of treatment

    Expires Mon Jan 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 8636997

    Method of treating multiple sclerosis with interferon-beta and an IL-2R antagonist

    Expires Mon Jan 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 8633177

    Nitroxyl (HNO) releasing compounds and uses thereof in treating diseases

    Expires Mon Jan 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 8632782

    Recombinant attenuated dengue viruses comprising mutations in NS5 and the 3′ untranslated region

    Expires Mon Jan 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 8632771

    High molecular weight derivatives of vitamin K-dependent polypeptides

    Expires Mon Jan 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 8628764

    Biocontrol of storage maladies of potatoes by bacterial antagonists produced in co-culture

    Expires Mon Jan 09 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 8628780

    Lutzomyia longipalpis polypeptides and methods of use

    Expires Mon Jan 09 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 8628962

    Differentiation of stem cells into dopaminergic cells

    Expires Mon Jan 09 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 8628782

    Deletion of the beta 20-21 loop in HIV gp120 exposes the CD4 binding site for improved antibody binding and antibody induction

    Expires Mon Jan 09 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 8629260

    Anti-arthropod vector vaccines, methods of selecting and uses thereof

    Expires Mon Jan 09 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 8623383

    Recombinant antigens for diagnosis and prevention of spotted fever rickettsiae

    Expires Mon Jan 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 8623371

    Targeting poly-gama-glutamic acid to treat Staphylococcus epidermidis and related infections

    Expires Mon Jan 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 8623828

    Blocking mesothelin peptide fragments

    Expires Mon Jan 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 8618090

    Inhibitors of the plasmodial surface anion channel as antimalarials

    Expires Mon Dec 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 8613905

    Diagnostic agent

    Expires Mon Dec 19 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 8613932

    GP100-specific T cell receptors and related materials and methods of use

    Expires Mon Dec 19 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 8613933

    Brachyury polypeptides and methods for use

    Expires Mon Dec 19 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 8613934

    Cellular and viral inactivation

    Expires Mon Dec 19 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 8614304

    Immunogenic peptides and methods of use for treating and preventing cancer

    Expires Mon Dec 19 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 8609728

    Treatment for pulmonary hypertension

    Expires Mon Dec 12 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 8609607

    Modified defensins and their use

    Expires Mon Dec 12 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does United Therapeutics Europe have?

3,720 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do United Therapeutics Europe patents expire?

234 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.